microfluidics Deepcell, UCLA Partner to Study AI Cell Biology Platform The company said the collaboration is the first under an academic partnership program to refine and advance its technology and explore specific applications. TellBio, ARUP Laboratories to Explore CTC Collection Platform for Cancer Research Premium ARUP hopes to use TellBio's platform for several applications in solid tumor types, including prostate and gynecological cancers. With Finder Platform, Baebies Works to Expand Options for Neonatal Dx Testing Premium The instrument, which is undergoing the FDA clearance process, has the capability to do PCR testing, clinical chemistry, and immunoassays. Namocell, SingLab Technologies Ink Distribution Agreement for Singapore Under the agreement, SingLab will distribute the Mountain View, California-based company's single-cell isolation systems in Singapore. Nuclera Acquires E Ink Digital Microfluidics Business UK-based Nuclera said it will integrate E Ink's microfluidics technology into its own platform to create a desktop protein and gene bioprinter. May 12, 2021 Berkeley Lights to Launch Subscription Option for Smaller Biotech Firms Premium May 11, 2021 Berkeley Lights Q1 Revenues Grow 35 Percent Mar 31, 2021 Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay Premium Mar 29, 2021 Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag Mar 18, 2021 Namocell, OLS OMNI Life Science Sign European Distribution Agreement Mar 3, 2021 Deepcell Advancing AI-Driven Cell Morphology Tech for Single-Cell Genomics, Liquid Biopsy Premium Feb 25, 2021 Miroculus Raises $45M in Extended Series B Financing Feb 10, 2021 Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth Jan 25, 2021 Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets Premium Dec 28, 2020 COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020 Premium Dec 18, 2020 BioView, Ruby Nanomed Form Circulating Tumor Cell Analysis Partnership Dec 7, 2020 Deepcell Closes $20M Series A Financing Round Nov 18, 2020 Stanford Researchers Combine CRISPR, Microfluidics, Electric Fields for SARS-CoV-2 Dx Premium Nov 17, 2020 New NGS-Based Tissue Analysis Method Offers Spatial Detail on Transcriptome, Proteins Premium Nov 9, 2020 Savran Technologies to Target Breast Cancer Recurrence with Circulating Tumor Cell Platform Premium Nov 5, 2020 Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing Oct 8, 2020 Fluidigm to Offer Coronavirus Saliva Test to US Colleges, Universities at Low Cost Sep 29, 2020 Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production Sep 9, 2020 LexaGene Closes C$13.3M Funding Round Sep 8, 2020 Scope Fluidics Secures €10M Loan From European Investment Bank Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.